Sort
48,018 grants matching “immunotherapy”
ADJUVANT IMMUNOTHERAPY TO REVERSE IMMUNOSUPPRESSION IN BURN-INJURED PATIENTS WITH ANTIBIOTIC-RESISTANT INFECTIONS
$1,407,585Washington University, The · · FY2022 · Defense Health Agency
Protein Expression Facility
$1,405,912Robert Petrovich · National Institute Of Environmental Health Sciences · ZIC · FY2023 · ES
SAN DIEGO AND SOUTHWESTERN PRIMARY INFECTION PROGRAM
$1,405,758University Of California San Diego · U01 · FY2001 · AI
Overcoming resistance to BRAF(V600E) targeted therapies in melanoma
$1,405,454David E Fisher · Massachusetts General Hospital · P01 · FY2015 · CA
TRANSFORMING TRIPLE-NEGATIVE BREAST CANCER TREATMENT THROUGH INTRATUMORAL IMMUNOTHERAPY VIA NANOFLUIDIC DRUG-ELUTING SEED
$1,404,919The Methodist Hospital Research Institute · · FY2020 · Defense Health Agency
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP) UG1
$1,404,651Anne S Tsao · University Of Tx Md Anderson Can Ctr · UG1 · FY2024 · CA
Structural and functional characterization of T and NK cell receptors
$1,404,240Peter D. Sun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Cellular Vaccines for Cancer Therapy
$1,404,012University Of Michigan At Ann Arbor · P01 · FY2002 · CA
Radiation-induced molecular targets
$1,403,058Norman Coleman · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies
$1,402,170Anish Thomas · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Combinatorial Engineering of Multicellular Synthetic Immunotherapy Systems
$1,400,954Kyle Gabriel Daniels · Stanford University · DP2 · FY2025 · EB
Children's Oncology Group Statistics and Data Center
$1,400,842Todd A Alonzo · Public Health Institute · U10 · FY2022 · CA
The connection of innate and adaptive anti-cancer immunity
$1,400,831John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
COLORADO ADULT AIDS CLINICAL TRIALS UNIT
$1,400,642University Of Colorado Denver · U01 · FY2002 · AI
HIV-1 and host interactions at molecular level
$1,400,080Maureen Goodenow · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
EXTRAMURAL FACIL IMPROVEMENT PROG: CANCER &IMMUNOTHERAPY, AIRWAY INFLAMMATION,
$1,400,000University Of Wisconsin Madison · C06 · FY2004 · RR
Clinical Islet Transplantation: Data Coordinating Center
$1,400,000William R Clarke · University Of Iowa · U01 · FY2008 · DK
Cytokines in AIDS and Cancer Immunotherapy
$1,399,536George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
DNA Sequencing and FACS Core Facilities
$1,399,321Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
EpCAM (CD326) Function in Epithelial Cell Biology and Immunophysiology
$1,398,920Mark Udey · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
MIXED HEMATOPOIETIC CHIMERISM AFTER STEM CELL ALLOGRAFTS
$1,398,609Fred Hutchinson Cancer Research Center · P01 · FY2000 · CA
Clinical Trials of Patients with AIDS-Related Malignancies
$1,398,422Robert Yarchoan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
BONE MARROW TRANSPLANTATION FOR BREAST CANCER
$1,397,933Duke University · P01 · FY2000 · CA
Heat Shock Protein and Thermal Therapy of Cancer
$1,396,711John R. Subjeck · Roswell Park Cancer Institute Corp · P01 · FY2006 · CA
Heat Shock Protein and Thermal Therapy of Cancer
$1,396,380John R. Subjeck · Roswell Park Cancer Institute Corp · P01 · FY2007 · CA